An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
A new study reveals that IL-12, an inflammatory molecule, accelerates Alzheimer’s disease by damaging brain cells and ...
Microglia, the brain's immune cells, usually serve as diligent guardians. They eliminate intruders such as microbes and clear ...
PsyPost on MSN3d
Semaglutide reduces brain inflammation and improves memory in an Alzheimer’s modelA new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback